Medication info
Il Yang Bio Atorvastatin Calcium Trihydrate Tablet 10 mg

Il Yang Bio Atorvastatin Calcium Trihydrate Tablet 10 mg

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Hydrate›10.845mg / 1 tablet
Manufacturer / importer
Il Yang Biopharm Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307346 · Approved 2013.05.15 · Insurance code 696600920

Summary

Main use
Improvement of hyperlipidemia (including in children), prevention of cardiovascular disease (such as myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of more than 45%). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, treatment goals, and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
Child dose
Ages 10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Il Yang Biopharm Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including in children), prevention of cardiovascular disease (such as myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • fatal and non-fatal stroke
  • congestive heart failure
  • angina
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. For example, it reduces the risk of myocardial infarction or stroke and lowers the risk of vascular surgeries and angina. It is particularly effective in reducing the risk of heart disease in high-risk groups such as patients with type 2 diabetes. Additionally, it improves the blood lipid levels in patients with primary hypercholesterolemia and dyslipidemia, decreasing cholesterol and triglycerides while increasing good cholesterol (HDL). It is also effective when used in conjunction with dietary therapy in children and adolescents with hypercholesterolemia. Therefore, this medication is used to reduce the risk of heart disease and dyslipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of more than 45%). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, treatment goals, and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.

Child dose

Ages 10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle issues, so if there is an increase in muscle pain, weakness or significantly elevated creatine kinase levels, take it immediately, stop taking it, and consult a doctor. Patients with an allergy to this drug, severe liver disease, pregnant women or women who may become pregnant, children under 10 years of age, or patients taking certain hepatitis medications should not take this drug. Those with liver or kidney issues or those who consume alcohol heavily, elderly patients, and those with a history of muscle diseases need to be particularly cautious when taking this medication and may require regular examinations. This drug typically has few side effects, but symptoms like indigestion, headache, muscle pain, fatigue, liver function abnormalities, and skin rashes may occur. If symptoms are severe, notify the healthcare provider. In particular, if muscle pain or weakness occurs, immediately inform a doctor and check for muscle damage through blood tests. This medication is metabolized in the liver, so taking it with certain antibiotics, antifungals, or antivirals may increase drug concentration and the risk of side effects, so it is essential to inform the doctor or pharmacist of any other medications being taken. Pregnant or breastfeeding women should not take this drug, and women of childbearing age should use appropriate contraception while taking it. The long-term safety in children and adolescents has not been sufficiently studied, so it should be taken according to a doctor’s guidance. There are no specific antidotes for overdose, so treatment should depend on the symptoms, and liver function and muscle status should be routinely checked. This medication should be kept out of reach of children and stored in its original container. Transferring it to another container may increase the risk of misuse or quality degradation.

Side effects

  • Apathy
  • fatigue
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 133 more
  • loss of appetite
  • constipation
  • abdominal distention
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal-laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disorder
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • fatigue
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive anomalies
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • corneal edema
  • loss of taste
  • taste disorder
  • sweating
  • acne
  • eczema
  • skin ulcer
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • urticaria
  • eczema
  • seborrhea
  • skin ulcer
  • itching
  • rash
  • alopecia
  • gingival hypertrophy
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • hypothermia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture entry. It is best to maintain storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.